IRImplementing rule
ATCO.MED.A.010Definitions
For the purpose of this Part, the following definitions apply:
(a)‘Accredited medical conclusion’ means the conclusion reached by one or more medical experts acceptable to the licensing authority, on the basis of objective and non-discriminatory criteria, for the purposes of the case concerned, in consultation with operational experts or other experts as necessary and including an operational risk assessment;
(b)‘Aero-medical assessment’ means the conclusion on the medical fitness of an applicant based on the evaluation of the applicant's medical history and aero-medical examinations as required in this Part and further examinations and medical tests as necessary;
(c)‘Aero-medical examination’ means inspection, palpation, percussion, auscultation or any other means of investigation especially for determining the medical fitness to exercise the privileges of the licence;
(d)‘Eye specialist’ means an ophthalmologist or a vision care specialist qualified in optometry and trained to recognise pathological conditions;
(e)‘Investigation’ means the assessment of a suspected pathological condition of an applicant by means of examinations and tests to verify the presence or absence of a medical condition;
(f)‘Licensing authority’ means the competent authority of the Member State that issued the licence, or to which a person applies for the issue of a licence, or, when a person has not yet applied for the issue of a licence, the competent authority in accordance with this Part;
(g)‘Limitation’ means a condition placed on the medical certificate that shall be complied with whilst exercising the privileges of the licence;
(h)‘Refractive error’ means the deviation from emmetropia measured in dioptres in the most ametropic meridian, measured by standard methods;
(i)‘Significant’ means a degree of a medical condition, the effect of which would prevent the safe exercise of the privileges of the licence.
IR · ATCO.MED.A.010 — Regulation (EU) 2015/340 · ATCO Easy Access Rules · EAR revision 14 Jun 2024